title: Evidence 2016--A Health Network Communications Conference (February 24-25, 2016--London, UK).
abstract: Defining, standardizing and interpreting are the keys to evidence use throughout healthcare and at each point in the care decision process. The generation of evidence at each step is also critical to define and constitute value from the information gathered, and not gathered, for each stakeholder in the care pathway. Health Network Communications' Evidence 2016 conference provided the opportunity for attendees to consider diverse evidence methodologies globally and their wide-ranging use, from economic modeling initiatives, to framing value assessments in health technology assessments, to leveraging real-world data to support market access.
authors.affiliation: Thomson Reuters, London, UK. alexandra.kibble@thomsonreuters.com.
authors.forename: A
authors.initials: A
authors.lastname: Kibble
mesh_terms: D059451:Biosimilar Pharmaceuticals; D003625:Data Collection; D016208:Databases, Factual; D016527:Drug Costs; D004345:Drug Industry; D019317:Evidence-Based Medicine; D019981:Health Care Sector; D006801:Humans; D007564:Japan; D008131:London; D061108:Social Media; D006113:United Kingdom; D014481:United States; D062505:Value-Based Purchasing
chemical_list: D059451:Biosimilar Pharmaceuticals
keywords: Big data; Biosimilars; Health technology assessments; Real-world data